κ-opioid receptor activation modifies dopamine uptake in the nucleus accumbens and opposes the effects of cocaine

Journal of Neuroscience

Volumn 20, Issue 24, 2000, Pages 9333-9340

  Thompson, Alexis C ^a,d   Zapata, Agustin ^a   Justice Jr , Joseph B ^b   Vaughan, Roxanne A ^c   Sharpe, Lawrence G ^a   Shippenberg, Toni S ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b EMORY UNIVERSITY   (United States)

^c UNIVERSITY OF NORTH DAKOTA SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^d UNIVERSITY AT BUFFALO   (United States)

Author keywords

Autoradiography; Cocaine; Dopamine; Dopamine uptake; Nucleus accumbens; Quantitative microdialysis; Rats; Rotating disk electrode voltammetry; Striatum; Western blot; opioid receptors

Indexed keywords

COCAINE; DOPAMINE TRANSPORTER; KAPPA OPIATE RECEPTOR; N METHYL N [7 (1 PYRROLIDINYL) 1 OXASPIRO[4.5]DEC 8 YL]BENZENEACETAMIDE;

ABSTINENCE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOPAMINE UPTAKE; DOPAMINERGIC SYSTEM; GENE ACTIVATION; MALE; MICRODIALYSIS; NEUROMODULATION; NEUROTRANSMISSION; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM;

EID: 0034671384     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.20-24-09333.2000     Document Type: Article

References (58)

1. β γ subunits
2. Mitogenic signaling via endogenous κ-opioid receptors in C6 glioma cells: Evidence for the involvement of protein kinase C and the mitogen-activated protein kinase signaling cascade
3. Steady-state theory for quantitative microdialysis of solutes and water in vivo and in vitro
4. Human norepinephrine transporter kinetics using rotating disk electrode voltammetry
5. Quantitative microdialysis of serotonin and norepinephrine: Pharmacological influences on in vivo extraction fraction
6. Regulated trafficking of the human dopamine transporter. Clathrin-mediated internalization and lysosomal degradation in response to phorbol esters
7. Opposite effects of mu and kappa opiate agonists on dopamine release in the nucleus accumbens and in the dorsal caudate of freely moving rats
8. Kappa agonist-induced reduction in dopamine release: Site of action and tolerance
9. Effects of repeated administration of a kappa-opioid agonist on phorbal ester binding to membrane-bound protein kinase C in rat brain
10. U-69593 prevents cocaine sensitization by normalizing basal accumbens dopamine
11. The kappa-opioid receptor agonist U-69593 attenuates cocaine-induced behavioral sensitization in the rat
12. Role of extracellular dopamine in the initiation and long-term expression of behavioral sensitization to cocaine
13. The persistence of behavioral sensitization to cocaine parallels enhanced inhibition of nucleus accumbens neurons
14. Electrophysiological effects of cocaine in the mesoaccumbens dopamine system: Repeated administration
15. Extremely longlasting antagonistic actions of nor-binaltorphimine (nBNI) in the mouse tail-flick test
16. max
17. Repeated administration of a selective kappa-opioid receptor agonist decreases dopamine transporter number in the nucleus accumbens of the rat
18. Different effects of cocaine and nomifensine on dopamine uptake in the caudate-putamen and nucleus accumbens
19. Quantitative microdialysis of neurotransmitters
20. Time course of extracellular dopamine and behavioral sensitization to cocaine. I. Dopamine axon terminals
21. Time course of extracellular dopamine and behavioral sensitization to cocaine. II. Dopamine perikarya
22. Dopamine transmission in the initiation and expression of drug- and stress-reduced sensitization of motor activity
23. Dopamine transporter site-directed mutations differentially alter substrate transport and cocaine binding
24. Nature of methamphetamine-induced rapid and reversible changes in dopamine transporters
25. Receptor autoradiography
26. The dopamine hypothesis of the reinforcing properties of cocaine
27. 3H]U-69593: A highly selective ligand for the opioid kappa receptor
28. The dopamine transporter carboxyl-terminal tail. Truncation/substitution mutants selectively confer high affinity dopamine uptake while attenuating recognition of the ligand binding domain
29. Regulation of rat dopamine transporter mRNA and protein by chronic cocaine administration
30. Repeated exposures intensify rather than diminish the rewarding effects of amphetamine, morphine, and cocaine
31. A microdialysis method allowing characterization of intercellular water space in humans
32. Microdialysis of intercellular adenosine concentration in subcutaneous tissue in humans
33. U50,488, a kappa opioid receptor agonist, attenuates cocaine-induced increases in extracellular dopamine in the nucleus accumbens of rats
34. Effects of cocaine and repeated cocaine followed by withdrawal: Alterations of dopaminergic transporter turnover with no changes in kinetics of substrate recognition
35. Membrane trafficking regulates the activity of the human dopamine transporter
36. Effects of kappa opioid agonists on cocaineand food-maintained responding by rhesus monkeys
37. Increased stimulated release and uptake of dopamine in nucleus accumbens after repeated cocaine administration as measured by in vivo voltammetry
38. Basal extracellular dopamine is decreased in the rat nucleus accumbens during abstinence from chronic cocaine
39. A multisubstrate kinetic mechanism of dopamine transport in the nucleus accumbens and its inhibition by cocaine
40. Cocaine receptors monoamine transporters and sodium channels
41. Cocaine inhibition of ligand binding at dopamine, norepinephrine and serotonin transporters: A structureactivity relationship
42. Rotating disk voltametric measurements in neurobiology and neuropharmacology
43. Sensitization and tolerance in psychostimulant self-administration
44. Kappa-opioid receptor agonist, U-69593, dowregulates the dopamine transporter in mesolimbic regions of the rat brain
45. Sensitization to the condition d rewarding effects of cocaine: Pharmacological and temporal characteristics
46. kappa-Opioid receptor agonists prevent sensitization to the conditioned rewarding effects of cocaine
47. The effect of inhibition of synthesis, release, metabolism and uptake on the microdialysis extraction fraction of dopamine
48. 3H]dopamine release from rat ventral mesencephalic dissociated cell cultures
49. Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway
50. Evidence that norbinaltorphimine can function as an antagonist at multiple opioid receptor subtypes
51. Tolerance and sensitization to the behavioral effects of drugs
52. Dopamine transporter ligand binding domains
53. Recognition of dopamine transporters by antipeptide antibodies
54. Protein kinase C-mediated phosphorylation and functional regulation of dopamine transporters in striatal synaptosomes
55. Regulation of dopamine uptake in rat striatal tissue by NMDA receptors as measured using rotating disk electrode voltammetry
56. A psychomotor stimulant theory of addiction
57. 2+ pathway in the cardiac κ-opioid receptor